Clinical Trials List
Protocol NumberD4200C00047
Completed
2007-04-30 - 2008-09-04
Phase II
Terminated2
ICD-10C18.3
Malignant neoplasm of hepatic flexure
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.0
Malignant neoplasm of hepatic flexure colon
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 姚乃舜 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
96 participants
